Solesence (SLSN) Stock Price, News & Analysis

Company Overview

Solesence is a skincare company focused on developing and commercializing science-based products designed to support skin health and improve the appearance of skin. The company combines cosmetic, dermatological and photoprotection research to create topical formulations for consumers and professional skincare markets.

Its product offerings include skincare solutions intended to address concerns such as visible signs of aging, skin discoloration and damage associated with environmental exposure. Solesence emphasizes proprietary formulations, active ingredients and evidence-based product development across categories that may include daily skincare and sun protection.

The company serves the beauty, wellness and medical aesthetics sectors through brand, retail and professional distribution channels. Solesence is headquartered in the United States and markets its products to customers in domestic and international markets.

Key Stats

• Today's Range: $0.80 to $0.83
• 50-Day Range: $0.80 to $1.07
• 52-Week Range: $0.61 to $4.00
• Volume: 9,192 shs
• Average Volume: 54,210 shs
• Market Capitalization: $57.58 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Solesence Stock Analysis - MarketRank™

Solesence scored higher than 1% of companies evaluated by MarketBeat, and ranked 166th out of 166 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Solesence has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Solesence has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Solesence is -27.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Solesence is -27.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Solesence has a P/B Ratio of 3.26. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

0.55% of the float of Solesence has been sold short.

Short Interest Ratio / Days to Cover

Solesence has a short interest ratio ("days to cover") of 17.22, which indicates bearish sentiment.

Change versus previous month

Short interest in Solesence has recently increased by 0.78%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Solesence does not currently pay a dividend.

Dividend Growth

Solesence does not have a long track record of dividend growth.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 0.9 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Solesence insiders have not sold or bought any company stock.

Percentage Held by Insiders

4.80% of the stock of Solesence is held by insiders.

Percentage Held by Institutions

70.22% of the stock of Solesence is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 11/13/2025
• Today: 10/09/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Consumer Staples
• Industry: Personal Care Products
• Sub-Industry: Personal Care Products
• Current Symbol: NASDAQ:SLSN
• Previous Symbol: NASDAQ:SLSN
• CIK: 883107
• Web: www.solesence.com
• Phone: (630) 771-6078
• Fax: 630-771-0825
• Employees: 115
• Year Founded: 1989

Profitability

• EPS (Trailing Twelve Months): ($0.03)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $1.79 million
• Net Margins: -3.40%
• Pretax Margin: -4.99%
• Return on Equity: -11.58%
• Return on Assets: -3.79%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.97
• Quick Ratio: 0.47

Sales & Book Value

• Annual Sales: $62.06 million
• Price / Sales: 0.93
• Cash Flow: $0.04 per share
• Price / Cash Flow: 21.51
• Book Value: $0.25 per share
• Price / Book: 3.26

Miscellaneous

• Outstanding Shares: 70,650,000
• Free Float: 67,256,000
• Market Cap: $57.58 million
• Optionable: N/A
• Beta: 1.37